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ABSTRACT
Background and aims Socioeconomic deprivation
(SED) is associated with increased mortality after stroke,
however, its associations with stroke care remains
uncertain. We assessed the SED impacts on acute and
long-term stroke care, and examined their ethnic
differences and secular trends.
Methods We used data from 4202 patients with
ﬁrst-ever stroke (mean age 70.1 years, 50.4% male,
20.4% black), collected by a population-based stroke
register in South London, England from 1995 to 2010.
Carstairs deprivation score was measured for each
patient, taking the 1st as the least deprived and the
2nd to 5th quintiles as SED, and was related to 20
indicators of care in multivariate logistic regression
models.
Results Patients with SED had 29% and 35%
statistically signiﬁcant reductions in odds of being
admitted to hospital and having swallow tests,
respectively. The multivariate adjusted odds ratio (OR)
for receiving ﬁve indicators of acute stroke care was
0.81 (95% CI 0.72 to 0.92). It was 0.76 (0.58 to
0.99) in black patients and 0.82 (0.71 to 0.96) in
white patients; and 0.70 (0.58 to 0.84) in patients
with stroke occurring before 2001 and 0.89 (0.75 to
1.05) since 2001. SED was further associated with
receipt of some stroke care during 5 years of follow-up,
including atrial ﬁbrillation medication (0.63, 0.48 to
0.83), and in black patients physiotherapy and
occupational therapy (0.32, 0.11 to 0.92).
Conclusions Stroke healthcare inequalities in England
exist for some important indicators, although overall it
has improved over time. The impact of SED may be
stronger in black patients than in white patients.
Further efforts are required to achieve stroke care
equality.
INTRODUCTION
Stroke is the leading cause of adult disability and is
the second highest cause of death in the world.1
Previous research has shown that people in low
socioeconomic groups have a signiﬁcantly increased
risk of stroke.2 There is also substantial evidence
for the existence of a socioeconomic gradient in
recurrences and mortality.2–5 However, the reasons
for these ﬁndings of poor prognosis of stroke
among patients with socioeconomic deprivation
(SED) are not well understood. Some but not all
studies have shown an association of SED with
poor provision of acute care after stroke.2 6 This
uncertainty also holds true in high-income coun-
tries.5 7–9 Furthermore, the SED impact on long-
term stroke care remains unclear.2 6 Although more
people of minority ethnic populations live in
Western countries and are more likely to experience
socioeconomic disadvantage than their white coun-
terparts, few studies have been done to investigate
socioeconomic inequalities among ethnic minorities
on accessing stroke care. While many governments
have campaigned to reduce health inequality in
stroke for decades,6 10 11 little is known about
whether the SED impact on access to stroke care
has changed over time.
In this study we examined the association of SED
with the provision of acute and long-term stroke
care, using data from a population register covering
an inner city multiethnic population in England.12
We further investigated secular trends and ethnic
differences in the impact of SED.
METHODS
Patients and provision of stroke care data
collection
The study population was derived from the South
London Stroke Register (SLSR).12 13 Its method-
ology has been fully described before.12 14 15 In
brief, the SLSR is an ongoing prospective
population-based stroke register set up in January
1995, recording all ﬁrst-ever strokes in patients of
all ages living in 22 electoral wards in Lambeth and
Southwark (total population at the 2001 census
was 271 817), inner city South London.13 16 In this
study, we included all data collected until 31
December 2010.
We identiﬁed patients using multiple sources of
notiﬁcation by specially trained study nurses and
ﬁeldworkers, from hospital and community surveil-
lances for stroke.13 16 Patients or their relatives
gave written informed consent to participate in the
study. Patients’ ethnicity was recorded by self deﬁn-
ition of ethnic origin (2001 UK census question)
stratiﬁed into white, black (black Caribbean, black
African and black other) and other ethnic groups
(South Asians (Indian, Pakistani, Bangladeshi),
Chinese, other Asians, etc). According to patients’
postcode of residence at the time of stroke, we cal-
culated the Carstairs deprivation index score17 to
measure baseline SED for each patient, as we did in
previous studies.18 19 The Carstairs index is an
area-based measure of SED derived from decennial
census data, using levels of male unemployment,
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overcrowding, car ownership and proportion in social classes IV
and V (partly skilled and unskilled) in a small area.17 20 The index
was derived using 2001 census data for each lower layer super
output area covered by the register.17 20 The higher the score, the
more deprived. The Carstairs deprivation index has been validated
and widely used in health-related studies in the UK.17–19
The diagnosis of stroke, using the WHO clinical deﬁnition,
was veriﬁed by a study clinician, and patients were examined
Table 1 Characteristics of patients with stroke across socioeconomic deprivation groups in SLSR of 1995–2010
Variable
Socioeconomic deprivation (Carstairs score—quintile)
p Value
Deprived (2nd–5th Q)
N=3361
Least deprived (1st Q)
N=841
n Per cent n Per cent
Age (years), median, IQR 72.6 (61.5–81.1) 72.3 (61.9–81.3) 0.602
Male sex, n (%) 1707 50.8 410 48.9 0.539
Ethnicity, n (%)*
White 2417 71.9 581 69.1 0.019
Black 655 19.5 202 24.0
Other 201 6.0 41 4.9
Unknown 88 2.6 17 2.0
Year of stroke, n (%)
1995–1997 755 22.5 209 24.9 0.018
1998–2000 678 20.2 172 20.5
2001–2003 660 19.6 155 18.4
2004–2006 574 17.1 168 20.0
2007–2010 694 20.7 137 16.3
Living conditions before stroke, n (%)
Alone in private accommodation 1054 31.4 225 26.8 0.055
With others in private accommodation 1568 46.7 420 49.9
Nursing home or other 671 20.0 182 21.6
Unknown 68 2.0 14 1.7
BI prior to stroke, n (%)
20, independent 2490 74.1 622 74.0 0.695
15–19, mild disability 477 14.2 117 13.9
0–14, moderate-severe disability 224 6.7 55 6.5
Unknown 170 5.1 47 5.6
Stroke subtype, n (%)
Infarction 2471 73.5 631 75.0 0.575
Primary intracerebral haemorrhage 434 12.9 106 12.6
Subarachnoid haemorrhage (SAH) 170 5.1 42 5.0
Unclassified 149 4.4 38 4.5
Unknown 137 4.1 24 2.9
Glasgow coma scale score, n (%)
≥13 2303 68.5 589 70.0 0.129
<13 (impaired consciousness) 932 27.7 211 25.1
Unknown 126 3.8 41 4.9
Incontinence, n (%)
No 1731 51.5 422 50.2 0.553
Yes 1407 41.9 355 42.2
Unknown 223 6.6 64 7.6
Speech deficit, n (%)
Yes 1743 51.9 461 54.9 0.136
None 1308 30.9 230 27.4
Unknown 580 17.3 149 17.7
Swallow impairment, n (%)
Yes 1197 35.6 304 36.2 0.405
None 1752 52.1 448 53.3
Unknown 412 12.3 89 10.6
Motor deficit, n (%)
Present 2634 78.4 664 79.0 0.778
None 568 16.9 142 16.9
Unknown 159 4.7 35 4.2
*Patients’ ethnicity was recorded by self definition of ethnic origin (2001 UK census question) stratified into white, black (black Caribbean, black African and black other) and other
ethnic groups.
BI, Barthel index; SLSR, South London Stroke Register.
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within 48 h of being notiﬁed to the SLSR where possible. We
obtained the clinical details at the time of maximal impairment.
These included information on motor deﬁcit, swallowing (using
the 3 oz (85 ml) water swallow test), speech, visual impairments
and urinary incontinence. Classiﬁcation of stroke subtype
(ischaemic stroke or primary intracerebral haemorrhage) was
based on results from at least one of CTor MRI.
We examined a range of indicators of the processes of care
after an acute stroke, and the indicators for provision of
rehabilitation therapy (physiotherapy (PT) assessment within
72 h, occupational therapy (OT) within 7 days, and speech and
language therapy (SALT) within 7 days) for those with deﬁcits
for PT/OT deﬁned as visual ﬁeld defects, motor deﬁcits and
sensory deﬁcits, and for SALT, dysarthria, dysphagia and failed
swallow test. Since 2005 we also investigated other interven-
tions, including thrombolysis within 3 h of symptom onset if
ischaemic stroke; receipt of aspirin at any time within the 1st
week of stroke or within 48 h if ischaemic stroke; enteral
feeding (nasogastric or percutaneous endoscopic gastrostomy),
after a failed swallow test result; and provision of intravenous
ﬂuids.
Follow-up data were collected by validated postal or
face-to-face instruments with patients and/or their carers.
Patients were assessed at 3 months and annually after stroke. We
examined follow-up by a specialist or general practitioner (GP)
(available data from 2002), four indicators of rehabilitation
therapy provision for those with recorded deﬁcits (PT/OT and
SALT ≤1 year) and 11 indicators of appropriate management of
clinical risk factors (atrial ﬁbrillation, hypertension, hypercholes-
terolaemia, diabetes, antiplatelet treatment for ischemic stroke).
The study was approved by the ethics committees of Guy’s
and St Thomas’ Hospital Trust, King’s College Hospital,
Queen’s Square, and Westminster Hospital (London).
Statistical analysis
All analyses were performed with the STATA statistical package
for Windows (V.11.2, STATA Corporation, College Station,
Texas, USA). Patients were divided into two groups in terms of
SED status: those in the second to ﬁfth quintiles of Carstairs
scores deﬁned as having SED and others in the ﬁrst quintile as
the least deprived for analysis. This is because source population
of the SLSR had a higher mean Carstairs index than the general
population where we have taken participants having the ﬁrst
tertile of Carstairs score as a reference group in the data ana-
lysis.19 We examined differences in patients’ characteristics
between the two SED groups, using Kruskal-Wallis method for
continuous variables and the χ2 test for categorical variables.
Multivariate adjusted logistic regression models were employed
to investigate the associations of SED with short-term and long-
term stroke care. We calculated ORs and their 95% CIs for pro-
vision of acute and long-term stroke care among patients with
SED. We further performed stratiﬁed data analyses for black
patients and white patients and for strokes occurring in 1995–
2000 (ie, the earlier periods) and 2001–2010 (the later
periods), a period of policy-led drives to improve the quality of
stroke care in the UK. To increase the statistical power, we
pooled ORs for similar indicators of stroke care in ethnicity and
in the stroke occurring years, and where needed, in all patients
for 3 months to 5 years follow-up, according to the standard
methods which we used before.21 If heterogeneity of
within-indicator and between-indicator variation in those
selected indicators was signiﬁcant, a random effect model was
used; otherwise, a ﬁxed effect model used. We tested for an
interaction on between SED and period of stroke occurrence,
and patients’ ethnicity using a one-sided p value.22
RESULTS
From 1 January 1995 to 31 December 2010, 4212 people with
ﬁrst-ever stroke were registered, of whom 4202 had the
Carstairs index calculated for analysis. Their mean age at onset
was 70.1 years (IQR 61.6–81.1 years), 50.4% were male and
20.4% were black patients. Table 1 shows baseline character-
istics of these patients. Compared with those with the least
deprived, patients with SED were more likely to be white and
with stroke having occurred in the years of 2007–2010. We did
not ﬁnd signiﬁcant differences in age, sex, living conditions,
Barthel index prior to stroke, stroke subtype, Glasgow coma
score, incontinence, speech deﬁcit, swallow impairment and
motor deﬁcit between two SED groups (table 1).
Acute stroke care
Table 2 reports the speciﬁc interventions among patients after
stroke. Compared with those who were the least deprived,
patients with SED had signiﬁcantly less chance of being admit-
ted to hospital. There was a borderline signiﬁcant association of
SED with reduced swallow test, and the associations of SED
with stroke unit admission, >50% of stay on stroke unit and
brain imaging were not statistically signiﬁcant.
After adjustment for covariables, we observed the signiﬁcant
associations with hospital admission and swallow tests (table 3).
A small reduction in OR was found for stroke unit admission,
>50% stay and brain imaging, but none of these reached
Table 2 Interventions in acute stroke in SLSR of 1995–2010*
Variable
Socioeconomic deprivation (Carstairs score—quintile)
p Value
Deprived (2nd–5th Q)
N=3191
Least deprived (1st Q)
N=799
n Per cent n Per cent
Hospital admission, n (%) 2783/3191 87.8 721/799 90.2 0.019
Stroke unit admission,†n (%) 1518/2710 56.0 402/708 56.8 0.715
>50% of stay on stroke unit† 1135/2454 46.3 295/635 46.5 0.926
Brain imaging, n (%) 2827/3044 92.9 719/771 93.0 0.710
Swallow test,†n (%) 2524/2768 91.2 665/713 93.3 0.074
Values are numbers of patients with process/total number of patients with data on process measure (%) unless stated otherwise.
*Patients with a subarachnoid haemorrhage were excluded in this analysis because they have differing needs for acute care and are typically managed in neurosurgical wards following
different protocols. All data analysis excluding patients with subarachnoid haemorrhage (total n=3990 remained).
†Limited to patients admitted to hospital.
SLSR, South London Stroke Register.
Chen R, et al. J Neurol Neurosurg Psychiatry 2014;0:1–7. doi:10.1136/jnnp-2013-306413 3
Cerebrovascular disease
 group.bmj.com on April 14, 2014 - Published by jnnp.bmj.comDownloaded from 
conventional statistical signiﬁcance level. We pooled OR for
receiving these ﬁve indicators of acute care and found a signiﬁ-
cantly reduced OR of 0.81 (95% CI 0.72 to 0.92) in all
patients.
Stratiﬁed data analysis for ethnicity and for the period on
which stroke occurred showed that there may be a stronger SED
impact in black patients than in white patients (except for
swallow test), and in the earlier period compared with the later
period (table 3). The pooled-OR for receiving ﬁve indicators
was 0.76 (0.58 to 0.99) in black patients with SED and 0.82
(0.71 to 0.96) in white patients, interaction p=0.314, and 0.70
(0.58 to 0.84) in SED patients with stroke occurring before
2001 and 0.89 (0.75 to 1.05) with stroke occurring since 2001,
interaction p=0.030 (ﬁgure 1).
Data on receipt of interventions in acute care showed no stat-
istically signiﬁcant differences among two SED groups in receiv-
ing these interventions including thrombolysis, aspirin use
started at any time in acute phase and aspirin use started 48 h
after stroke, (see online supplementary table S1). Multivariate
adjusted analysis also suggested no signiﬁcant association of
SED with each intervention and with their combinations.
However, in black patients, after pooling the ORs from the six
interventions combined (thrombolysis, anytime aspirin, fed by
enteral route, intravenous ﬂuids, PT/OT and SALT), we found a
statistically signiﬁcant impact of SED (pooled-OR 0.48, 0.32 to
0.72), which was stronger that in white patients (0.89, 0.70 to
1.13), interaction p=0.005.
Long-term stroke care from hospital discharge to 5 years
follow-up
Of the total sample, 1097 (26.0%) died before 3 months, 2037
(48.4%) had a 3-month assessment and 1078 (25.6%) were lost
to follow-up (declined, not traced in time, or moved away). Two
thousand six hundred and sixty patients survived up to 1 year
and reached the 1 year follow-up point and 1917 were then
reassessed. The matched ﬁgures in years 2, 3, 4 and 5 were
2287 (1310), 1932 (1363), 1658 (1139) and 1406 (872),
respectively. There were no statistically signiﬁcant differences in
SED between patients reassessed and not reassessed, for
example, p=0.279 at 5 year follow-up.
In the follow-up, we collected data on access to specialist/GP
at 3 months and 1 year. Multivariate adjusted OR for patients
with SED receiving specialist/GP was not signiﬁcantly low, at
3 months 0.75 (0.52 to 1.10) and at 1 year 0.79 (0.36 to 1.73).
However, the OR at 3 months was signiﬁcantly reduced among
those whose stroke occurred in the later period (0.56, 0.31 to
0.98). No interaction effect was found for ethnicity and for
period in which stroke occurred.
Table 4 shows number, percentage and OR for receiving atrial
ﬁbrillation medication in eligible patients over 5 years follow-up.
The association of SED with receiving less atrial ﬁbrillation
medication was found at 3 months and 5 years, but not signiﬁ-
cantly at years 2–4. The pooled data from 3 months to years 1,
2, 3 and 5 showed an OR of 0.63 (0.48 to 0.83). In the strati-
ﬁed data analysis for ethnicity and for period on which stroke
occurred, we only observed a signiﬁcant OR of 0.40 (0.19 to
0.82) at 3 months for stroke occurring in the later period.
In data on prescribing medications for antihypertension, low-
ering blood cholesterol and glucose, and antiplatelet in eligible
patients, we did not observe that they were signiﬁcantly related
to SED, except for medication for lowering blood cholesterol at
3 months (multivariate adjusted OR 0.51, 0.32 to 0.83) and for
lowering glucose at 2 years (0.34, 0.15 to 0.80). The stratiﬁed
data analysis for ethnicity and for stroke years showed no
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signiﬁcant association of SED with these medications at each
time follow-up, except for lowering glucose medication (in
black patients, 0.33, 0.11 to 0.95 at 3 months and 0.16, 0.03 to
0.96 at 2 years).
There was no signiﬁcant association of SED with receiving
PT/OT and SALT at 3 months and 1, 2, 3, 4 and 5 years after
stroke. However, in the stratiﬁed data analysis we found that the
signiﬁcantly reduced OR was for black patients at year 3 to
receive PT/OT (0.32, 0.11 to 0.92).
DISCUSSION
In this multiethnic population of patients with stroke with long-
term follow-up, we found signiﬁcant associations of SED with
many provisions of acute and long-term stroke care. More indi-
cators of stroke care seemed to be inversely related to SED in
black patients than in white patients. There were more inequal-
ities in stroke care in those whose stroke occurred before 2001.
To our knowledge the current study is the ﬁrst to compare
SED impact on stroke care between white patients and black
patients who live in high-income countries. The SLSR data
includes the largest proportion of black and minority ethnicity
patients in the world. Although living in the same society in the
UK, black people generally have lower levels of education and
occupational class and are poorer than white people. These
offered a unique opportunity for us to identify the association
of SED with stroke care. A second strength is that our study
covered a long time period, with meticulous follow-up of the
patients with stroke. This allowed us to examine the impact of
SED on longer-term stroke care (which has been lacking in
study, before) and its secular trend, evaluating health policies.
Our study has some limitations. Although the study included a
large proportion of black and minority ethnicity patients, when
we stratiﬁed data analysis for ethnicity the number of events was
small, giving a wider CI in adjusted OR, which needs to be
taken with caution when interpreting the ﬁndings. However, we
employed meta-analysis techniques to pool data to further
examine the association of SED with stroke care; the ethnic dif-
ferences in the SED impacts were tested for signiﬁcance. Thus
the overall ﬁndings are robust. We had limited data on some
indicators of stroke care in terms of collection from 2005, for
example, receiving intervention for acute stroke, and we could
not examine differences in the impact of SED between the early
and the later periods. We do not have data on personal or
family income for each patient, while data of educational level
and occupational class include substantial missing values. We
could therefore not analyse their associations with provision of
stroke care. We will carry out more studies to investigate these,
including breaking down Carstairs index into several compo-
nents (eg, education, occupation) and further follow-up the
cohort.
Previous studies reported some signiﬁcant associations
between SED and stroke care, mainly acute care. In Nordic
countries, Langagergaard et al5 found that low-income patients
and disabled pensioners were less likely to receive seven speciﬁc
processes of care (including stroke unit care, scan, antiplatelet or
anticoagulation, assessment by physiotherapist or OT) after
stroke. The FINMONICA stroke register (a Finnish contribution
to the World Health Organization’s MONICA project
(MONItoring of trends and determinants of CArdiovascular
disease)7 reported that patients from high-income groups were
more likely to be treated at a university hospital, be examined
by a neurology specialist and have CT or MRI. In North
America, patients in the lowest-income group were less likely to
receive inhospital rehabilitation treatments and waited longer
for carotid endarterectomy,23 while patients from higher socio-
economic groups were more likely to receive post acute stroke
rehabilitation.24 In China, patients with stroke with lower
income and those without medical insurance were less likely to
receive antithrombotic therapy.25
Figure 1 Combined OR for receiving ﬁve indicators of care after stroke in patients with socioeconomic deprivation (SED) by ethnicity and by the
period in which stroke occurred.
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In the current study, we found that there were signiﬁcant
associations between SED and multiple components of acute
and long-term stroke care. The most important ﬁnding is that
there was a stronger impact of SED on provision of stroke care
in black patients than their white counterparts. Previous
studies26 mainly investigated ethnic differences in stroke care,
showing that black patients with stroke received fewer
evidence-based care processes. The current study has identiﬁed
that within black patients SED was associated with poor stroke
care, and the association may be stronger than in white
patients. This suggests that addressing healthcare inequality in
stroke in black patients may be behind that in whites, and strat-
egies for reducing health inequality should target on this
population.
Our study has shown that the impact of SED appears to have
attenuated with time, which may be associated with changes in
health policies, organisation of stroke services and the applica-
tion of new scientiﬁc evidence into clinical practice. It has prob-
ably reﬂected increased efforts in the UK to improve the quality
of stroke care through a raft of policy initiatives including the
National Stroke Strategy10 and a rolling national programme of
audit of clinical guideline implementation.11 27 This is a good
achievement in public health. However, signiﬁcantly reduced
ORs for specialist/GP follow-up and for atrial ﬁbrillation medi-
cation were observed in the later periods, and black patients
appeared to still have healthcare inequality in stroke. Our ﬁnd-
ings could help improve making of health policies.
We did not observe signiﬁcant associations of SED with other
indicators of stroke care, for example, antihypertensive and anti-
platelet medication, SALT, PT/OT (except in black patients).
This may suggest that the government has dealt with health
inequality in stroke care on these aspects or these are more
easily established as routine care for all patients with stroke. An
Austrian study also suggested no socioeconomic differences in
the administration of thrombolysis, or the rate of prescribing
secondary prevention drugs.8 Equal access to stroke unit care
and an apparent equity in thrombolysis provision among all
socioeconomic groups was reported in patients from three
Scottish hospitals with universal access to care.9 However, the
SLSR data showed that patients with SED had less chance of
being given medication for atrial ﬁbrillation in acute and long-
term phases. It is an interesting ﬁnding in the current study.
This would have an important implication and may help explain
a high level of mortality in patients with stroke with SED. We
need to carry out a further study to investigate its reasons and
reduce inequality in secondary stroke prevention. Nevertheless,
our study is of timely importance for clinicians and health
policy makers for reducing healthcare inequality and improving
the prognosis of stroke.
Variations in the ﬁndings of the association between SED
and stroke care provision may reﬂect different healthcare
systems among these countries and improvement on reducing
healthcare inequality in stroke over time. It may also be due to
different indicators of stroke care and duration of the
Table 4 Associations between socioeconomic deprivation and access to atrial fibrillation medical follow-up in SLSR of 1995–2010
Socioeconomic deprivation
Atrial fibrillation medication*
Yes No
p Value
Multivariate adjusted
n Per cent n Per cent OR† 95% CI p Value
At 3 months
Deprivation
No 45 35.2 47 18.5
Yes 83 64.8 207 81.5 0.000 0.46 0.27 to 0.79 0.005
At 1 year
Deprivation
No 37 30.8 53 22.5
Yes 83 30.7 183 77.5 0.086 0.75 0.42 to 1.31 0.311
At 2 years
Deprivation
No 22 25.3 37 20.6
Yes 65 74.7 143 79.4 0.382 0.93 0.45 to 1.94 0.856
At 3 years
Deprivation
No 27 29.0 33 22.3
Yes 66 71.0 115 77.7 0.239 0.69 0.33 to 1.43 0.316
At 4 years
Deprivation
No 19 25.0 33 23.7
Yes 57 75.0 106 76.3 0.837 0.79 0.36 to 1.72 0.554
At 5 years
Deprivation
No 21 32.8 19 16.7
Yes 43 67.2 95 83.3 0.013 0.39 0.17 to 0.88 0.024
*Based on patients having atrial fibrillation.
†OR—adjusted for age, sex, ethnicity, living conditions before stroke, period of stroke, BI (each analysis changed at its data collection), stroke subtype, Glasgow coma scale sore (≥13),
incontinence, speech deficit and motor deficit.
BI, Barthel index; SLSR, South London Stroke Register.
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follow-up. In this long-term follow-up study, using a compre-
hensive measurement of SED,19 20 we found an overall signiﬁ-
cant association with many indicators. Recently having
analysed data from Hospital Episode Statistics in England,
Lazzarino et al28 also reported that SED (measured using the
Carstairs index as well) was related to less chance of being
selected for emergency admission for stroke and for a brain
scan on the same day of admission in patients scanned at any
time in the same hospital. Our data further showed that the
impact of SED was greater in black patients. All these suggest
that stroke healthcare inequality still remains in England, par-
ticularly in an ethnic population. Our study may help explain
why patients with SED had a poorer prognosis of stroke than
patients who were not in SED.2 6
Conclusions
This study has shown an overall signiﬁcant association between
SED and reduced access to acute and long-term stroke care in a
multiethnic population of patients with stroke in England.
Inequalities in stroke care provision were more obviously
observed in black patients than in white patients. There were
improvements in some indicators over time. Reducing the
poverty in black and other minority populations may help
reduce health in equality in stroke nationally and internationally.
Further investigation is required to understand how these
improvements were achieved to address other aspects of stroke
care where inequalities in access remain.
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